Justin D. Blasberg

• Anne Chiang
• Chi Liu
• Daniel Boffa
• Danya Keene
• David C. Madoff
• Frank Detterbeck
• Gavitt Woodard
• Henry S. Park
• Jean-Dominique Gallezot
• Jeph Herrin
• Jun Lu
• Katie Gielissen
• Lynn Tanoue
• Marney White
• Matthew Pichert
• Maureen Canavan
• Michelle Salazar
• Mika Naganawa
• Ming-Kai Chen
• Paul Heerdt
• Robert Homer
• Roy S. Herbst
• Sajid A Khan
• Sarah Goldberg
• Scott Gettinger
• Theresa Ermer
• Vincent Mase

Robotics; Thoracic Surgery

• Thoracic CT follow-up after non-small-cell lung cancer resectionWoodard G, Boffa D, Blasberg J. Thoracic CT follow-up after non-small-cell lung cancer resection The Lancet Oncology 2022, 23: e484. PMID: 36328013, DOI: 10.1016/s1470-2045(22)00618-0.
• The Society of Thoracic Surgeons General Thoracic Surgery Database: 2022 Update on Outcomes and ResearchServais E, Blasberg J, Brown L, Towe C, Seder C, Onaitis M, Block M, David E. The Society of Thoracic Surgeons General Thoracic Surgery Database: 2022 Update on Outcomes and Research The Annals Of Thoracic Surgery 2022 DOI: 10.1016/j.athoracsur.2022.10.025.
• Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung CancerPichert MD, Canavan ME, Maduka RC, Li AX, Ermer T, Zhan PL, Kaminski M, Udelsman BV, Blasberg JD, Park HS, Goldberg SB, Boffa DJ. Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer JAMA Network Open 2022, 5: e2224478. PMID: 35925606, PMCID: PMC9353596, DOI: 10.1001/jamanetworkopen.2022.24478.
• Surgical Management of Pneumothorax and Pleural Space DiseaseDhanasopon AP, Blasberg JD, Mase VJ. Surgical Management of Pneumothorax and Pleural Space Disease Surgical Clinics Of North America 2022, 102: 413-427. PMID: 35671764, DOI: 10.1016/j.suc.2022.03.001.
• A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-makingDetterbeck FC, Blasberg JD, Woodard GA, Decker RH, Kumbasar U, Park HS, Mase VJ, Bade BC, Li AX, Brandt WS, Madoff DC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-making Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813719, PMCID: PMC9264102, DOI: 10.21037/jtd-21-1823.
• A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patientsDetterbeck FC, Mase VJ, Li AX, Kumbasar U, Bade BC, Park HS, Decker RH, Madoff DC, Woodard GA, Brandt WS, Blasberg JD. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813747, PMCID: PMC9264068, DOI: 10.21037/jtd-21-1824.
• A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumorsBade BC, Blasberg JD, Mase VJ, Kumbasar U, Li AX, Park HS, Decker RH, Madoff DC, Brandt WS, Woodard GA, Detterbeck FC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813753, PMCID: PMC9264070, DOI: 10.21037/jtd-21-1825.
• A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablationPark HS, Detterbeck FC, Madoff DC, Bade BC, Kumbasar U, Mase VJ, Li AX, Blasberg JD, Woodard GA, Brandt WS, Decker RH. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813762, PMCID: PMC9264060, DOI: 10.21037/jtd-21-1826.
• Microwave Ablation versus Stereotactic Body Radiotherapy for Stage I Non–Small Cell Lung Cancer: A Cost-Effectiveness AnalysisWu X, Uhlig J, Blasberg JD, Gettinger SN, Suh RD, Solomon SB, Kim HS. Microwave Ablation versus Stereotactic Body Radiotherapy for Stage I Non–Small Cell Lung Cancer: A Cost-Effectiveness Analysis Journal Of Vascular And Interventional Radiology 2022, 33: 964-971.e2. PMID: 35490932, DOI: 10.1016/j.jvir.2022.04.019.
• Brief Report: Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung CancerPichert MD, Canavan ME, Maduka RC, Li AX, Ermer T, Zhan PL, Kaminski M, Udelsman BV, Blasberg JD, Mase VJ, Dhanasopon AP, Boffa DJ. Brief Report: Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung Cancer JTO Clinical And Research Reports 2022, 3: 100318. PMID: 35540711, PMCID: PMC9079298, DOI: 10.1016/j.jtocrr.2022.100318.
• 109MO Respect the middle lobe: Perioperative survival of bilobectomy compared to lobectomy and pneumonectomyLi A, Canavan M, Ermer T, Kaminski M, Maduka R, Zhan P, Flores K, Boffa D, Blasberg J. 109MO Respect the middle lobe: Perioperative survival of bilobectomy compared to lobectomy and pneumonectomy Annals Of Oncology 2022, 33: s82. DOI: 10.1016/j.annonc.2022.02.136.
• Breast metastases from primary lung cancer: a retrospective case series on clinical, ultrasonographic, and immunohistochemical featuresWang B, Jiang Y, Li SY, Niu RL, Blasberg JD, Kaifi JT, Liu G, Wang ZL. Breast metastases from primary lung cancer: a retrospective case series on clinical, ultrasonographic, and immunohistochemical features Translational Lung Cancer Research 2021, 0: 0-0. PMID: 34430360, PMCID: PMC8350075, DOI: 10.21037/tlcr-21-542.
• Evolution of the N Descriptor Lymph Node Number vs Lymph Node LocationBlasberg JD, Li A. Evolution of the N Descriptor Lymph Node Number vs Lymph Node Location CHEST Journal 2021, 159: 2159-2160. PMID: 34099129, DOI: 10.1016/j.chest.2021.01.065.
• Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysisLi AX, Resio BJ, Canavan ME, Papageorge M, Boffa DJ, Blasberg JD. Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis Journal Of Thoracic Disease 2021, 0: 0-0. PMID: 34277037, PMCID: PMC8264694, DOI: 10.21037/jtd-21-1.
• High expression of cell adhesion molecule 2 unfavorably impacts survival in non-small cell lung cancer patients with brain metastasesDai L, Li YH, Liang YY, Zhao J, Chen G, Yin J, Postmus PE, Addeo A, Blasberg JD, Onesti CE, Liao ZW, Rao XG, Long HD. High expression of cell adhesion molecule 2 unfavorably impacts survival in non-small cell lung cancer patients with brain metastases Journal Of Thoracic Disease 2021, 13: 2437-2446. PMID: 34012591, PMCID: PMC8107517, DOI: 10.21037/jtd-21-307.
• Effectiveness of Thermal Ablation and Stereotactic Radiotherapy Based on Stage I Lung Cancer HistologyUhlig J, Mehta S, Case MD, Dhanasopon A, Blasberg J, Homer RJ, Solomon SB, Kim HS. Effectiveness of Thermal Ablation and Stereotactic Radiotherapy Based on Stage I Lung Cancer Histology Journal Of Vascular And Interventional Radiology 2021, 32: 1022-1028.e4. PMID: 33811997, DOI: 10.1016/j.jvir.2021.02.025.
• Adjuvant Chemotherapy for T4 Non-Small Cell Lung Cancer with Additional Ipsilateral Lung NodulesLi AX, Flores K, Canavan ME, Boffa DJ, Blasberg JD. Adjuvant Chemotherapy for T4 Non-Small Cell Lung Cancer with Additional Ipsilateral Lung Nodules The Annals Of Thoracic Surgery 2021, 113: 421-428. PMID: 33684345, DOI: 10.1016/j.athoracsur.2021.02.042.
• PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary AnalysisLee J, Chaft J, Nicholas A, Patterson A, Waqar S, Toloza E, Haura E, Raz D, Reckamp K, Merritt R, Owen D, Finley D, Mcnamee C, Blasberg J, Garon E, Mitchell J, Doebele R, Baciewicz F, Nagasaka M, Pass H, Schulze K, Phan S, Johnson A, Bunn P, Johnson B, Kris M, Kwiatkowski D, Wistuba I, Carbone D, Rusch V. PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis Journal Of Thoracic Oncology 2021, 16: s59-s61. DOI: 10.1016/j.jtho.2021.01.320.
• A Lower Tidal Volume Regimen during One-lung Ventilation for Lung Resection Surgery Is Not Associated with Reduced Postoperative Pulmonary Complications.Colquhoun DA, Leis AM, Shanks AM, Mathis MR, Naik BI, Durieux ME, Kheterpal S, Pace NL, Popescu WM, Schonberger RB, Kozower BD, Walters DM, Blasberg JD, Chang AC, Aziz MF, Harukuni I, Tieu BH, Blank RS. A Lower Tidal Volume Regimen during One-lung Ventilation for Lung Resection Surgery Is Not Associated with Reduced Postoperative Pulmonary Complications. Anesthesiology 2021, 134: 562-576. PMID: 33635945, PMCID: PMC8274370, DOI: 10.1097/aln.0000000000003729.
• The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy DecreasesSalazar MC, Canavan ME, Walters SL, Chilakamarry S, Ermer T, Blasberg JD, Yu JB, Gross CP, Boffa DJ. The Survival Advantage of Lobectomy over Wedge Resection Lessens as Health-Related Life Expectancy Decreases JTO Clinical And Research Reports 2021, 2: 100143. PMID: 34590002, PMCID: PMC8474228, DOI: 10.1016/j.jtocrr.2021.100143.
• A National Study of Surgically Managed Atypical Pulmonary Carcinoid TumorsWalters SL, Canavan ME, Salazar MC, Resio BJ, Blasberg JD, Mase V, Boffa DJ. A National Study of Surgically Managed Atypical Pulmonary Carcinoid Tumors The Annals Of Thoracic Surgery 2020, 112: 921-927. PMID: 33159862, DOI: 10.1016/j.athoracsur.2020.09.029.
• Commentary: A novel approach for localization of small lung nodulesBrandt WS, Blasberg JD. Commentary: A novel approach for localization of small lung nodules JTCVS Techniques 2020, 4: 305-306. PMID: 34318054, PMCID: PMC8308115, DOI: 10.1016/j.xjtc.2020.10.034.
• Navigating by Stars: Using CMS Star Ratings to Choose Hospitals for Complex Cancer SurgeryPapageorge MV, Resio BJ, Monsalve AF, Canavan M, Pathak R, Mase VJ, Dhanasopon AP, Hoag JR, Blasberg JD, Boffa DJ. Navigating by Stars: Using CMS Star Ratings to Choose Hospitals for Complex Cancer Surgery JNCI Cancer Spectrum 2020, 4: pkaa059-. PMID: 33134834, PMCID: PMC7583163, DOI: 10.1093/jncics/pkaa059.
• Thermal ablation versus stereotactic body radiotherapy for stage I non-small cell lung cancer: A cost-effectiveness analysis.Wu X, Uhlig J, Blasberg J, Gettinger S, Suh R, Solomon S, Kim K. Thermal ablation versus stereotactic body radiotherapy for stage I non-small cell lung cancer: A cost-effectiveness analysis. Journal Of Clinical Oncology 2020, 38: e21061-e21061. DOI: 10.1200/jco.2020.38.15_suppl.e21061.
• Invasive Staging Procedures Do Not Prevent Nodal Metastases From Being Missed in Stage I Lung CancerResio BJ, Canavan M, Mase V, Dhanasopon AP, Blasberg JD, Boffa DJ. Invasive Staging Procedures Do Not Prevent Nodal Metastases From Being Missed in Stage I Lung Cancer The Annals Of Thoracic Surgery 2020, 110: 390-397. PMID: 32283084, DOI: 10.1016/j.athoracsur.2020.03.026.
• 3:18 PM Abstract No. 148 Current United States nationwide utilization of thermal ablation for lung cancerUhlig J, Case M, Gettinger S, Blasberg J, Boffa D, Kim K. 3:18 PM Abstract No. 148 Current United States nationwide utilization of thermal ablation for lung cancer Journal Of Vascular And Interventional Radiology 2020, 31: s70. DOI: 10.1016/j.jvir.2019.12.182.
• Abstract No. 520 Stage 4 lung cancer: comparison of thermal ablation and stereotactic body radiotherapy for the pulmonary primaryUhlig J, Case M, Gettinger S, Blasberg J, Boffa D, Kim K. Abstract No. 520 Stage 4 lung cancer: comparison of thermal ablation and stereotactic body radiotherapy for the pulmonary primary Journal Of Vascular And Interventional Radiology 2020, 31: s227-s228. DOI: 10.1016/j.jvir.2019.12.581.
• Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer DatabaseSathe TS, Resio BJ, Hoag JR, Monsalve AF, Pathak R, Blasberg JD, Mase V, Dhanasopon A, Boffa DJ. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database The Annals Of Thoracic Surgery 2020, 109: 1656-1662. PMID: 32109449, DOI: 10.1016/j.athoracsur.2020.01.021.
• Robotic Thoracic SurgerySchwartz G, Sancheti M, Blasberg J. Robotic Thoracic Surgery Surgical Clinics Of North America 2020, 100: 237-248. PMID: 32169178, DOI: 10.1016/j.suc.2019.12.001.
• Understanding Entrustment Decision-Making by Surgical Program DirectorsAhle SL, Gielissen K, Keene DE, Blasberg JD. Understanding Entrustment Decision-Making by Surgical Program Directors Journal Of Surgical Research 2020, 249: 74-81. PMID: 31926399, DOI: 10.1016/j.jss.2019.12.001.
• OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3Oezkan F, He K, Owen D, Pietrzak M, Cho J, Kitzler R, Pearson R, Rusch V, Chaft J, Suh R, Blasberg J, Reckamp K, Raz D, Kneuertz P, Fiorillo L, Garon E, Nicholas A, Johnson A, Schulze K, Grindheim J, Banchereau R, Phan S, Bunn P, Kwiatkowski D, Johnson B, Kris M, Wistuba I, Lee J, Lozanski G, Carbone D. OA13.07 Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3 Journal Of Thoracic Oncology 2019, 14: s242-s243. DOI: 10.1016/j.jtho.2019.08.482.
• Can the Centers for Medicare and Medicaid Star Ratings Be Used as a Realistic Approach to Reduce Mortality in Complex Cancer Surgery?Papageorge M, Hoag J, Resio B, Monsalve A, Pathak R, Mase V, Dhanasopon A, Blasberg J, Boffa D. Can the Centers for Medicare and Medicaid Star Ratings Be Used as a Realistic Approach to Reduce Mortality in Complex Cancer Surgery? Journal Of The American College Of Surgeons 2019, 229: s144. DOI: 10.1016/j.jamcollsurg.2019.08.319.
• P2.04-88 Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical TrialLee J, Chaft J, Nicholas A, Patterson G, Waqar S, Toloza E, Haura E, Raz D, Reckamp K, Merritt R, Owen D, Finley D, Mcnamee C, Blasberg J, Garon E, Mitchell J, Doebele R, Baciewicz F, Nagasaka M, Pass H, Johnson A, Phan S, Schulze K, Bunn P, Johnson B, Kris M, Kwiatkowski D, Wistuba I, Carbone D, Rusch V. P2.04-88 Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial Journal Of Thoracic Oncology 2019, 14: s744. DOI: 10.1016/j.jtho.2019.08.1593.
• Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung AdenocarcinomaKurbatov V, Balayev A, Saffarzadeh A, Heller DR, Boffa DJ, Blasberg JD, Lu J, Khan SA. Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung Adenocarcinoma The Annals Of Thoracic Surgery 2019, 109: 343-349. PMID: 31568747, DOI: 10.1016/j.athoracsur.2019.08.050.
• A new approach to predicting risk for N2 disease in non-small cell lung cancerDecker RH, Blasberg JD. A new approach to predicting risk for N2 disease in non-small cell lung cancer Journal Of Thoracic Disease 2019, 1: s1973-s1975. PMID: 31632801, PMCID: PMC6783735, DOI: 10.21037/jtd.2019.07.61.
• Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung CancerUhlig J, Case MD, Blasberg JD, Boffa DJ, Chiang A, Gettinger SN, Kim HS. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer JAMA Network Open 2019, 2: e199702. PMID: 31433481, PMCID: PMC6707019, DOI: 10.1001/jamanetworkopen.2019.9702.
• Quality Versus QuantityChiu AS, Arnold BN, Hoag JR, Herrin J, Kim CH, Salazar MC, Monsalve AF, Jean RA, Blasberg JD, Detterbeck FC, Gross CP, Boffa DJ. Quality Versus Quantity Annals Of Surgery 2019, Publish Ahead of Print: &na;. PMID: 29697446, DOI: 10.1097/sla.0000000000002762.
• Benefit of combining local treatment and systemic therapy for stage IV NSCLC: Results from the National Cancer Database.Dendy Case M, Dendy Case M, Uhlig J, Uhlig J, Blasberg J, Boffa D, Chiang A, Gettinger S, Kim H, Kim H. Benefit of combining local treatment and systemic therapy for stage IV NSCLC: Results from the National Cancer Database. Journal Of Clinical Oncology 2019, 37: 8545-8545. DOI: 10.1200/jco.2019.37.15_suppl.8545.
• Differential Safety Between Top-Ranked Cancer Hospitals and Their Affiliates for Complex Cancer SurgeryHoag JR, Resio BJ, Monsalve AF, Chiu AS, Brown LB, Herrin J, Blasberg JD, Kim AW, Boffa DJ. Differential Safety Between Top-Ranked Cancer Hospitals and Their Affiliates for Complex Cancer Surgery JAMA Network Open 2019, 2: e191912. PMID: 30977848, PMCID: PMC6481444, DOI: 10.1001/jamanetworkopen.2019.1912.
• Quantitative FDG PET/CT may help risk-stratify early-stage non-small cell lung cancer patients at risk for recurrence following anatomic resectionHarmon S, Seder CW, Chen S, Traynor A, Jeraj R, Blasberg JD. Quantitative FDG PET/CT may help risk-stratify early-stage non-small cell lung cancer patients at risk for recurrence following anatomic resection Journal Of Thoracic Disease 2019, 11: 1106-1116. PMID: 31179052, PMCID: PMC6531752, DOI: 10.21037/jtd.2019.04.46.
• The Society of Thoracic Surgeons General Thoracic Surgery Database 2019 Update on Outcomes and QualitySeder CW, Magee MJ, Broderick SR, Brown LM, Blasberg JD, Kozower BD, Fernandez FG, Welsh R, Gaissert HA, Burfeind W, Becker S, Raymond D. The Society of Thoracic Surgeons General Thoracic Surgery Database 2019 Update on Outcomes and Quality The Annals Of Thoracic Surgery 2019, 107: 1302-1306. PMID: 30898564, DOI: 10.1016/j.athoracsur.2019.02.027.
• Prophylactic cranial irradiation is associated with improved survival following resection for limited stage small cell lung cancerResio BJ, Hoag J, Chiu A, Monsalve A, Dhanasopon AP, Boffa DJ, Blasberg JD. Prophylactic cranial irradiation is associated with improved survival following resection for limited stage small cell lung cancer Journal Of Thoracic Disease 2019, 11: 811-818. PMID: 31019769, PMCID: PMC6462708, DOI: 10.21037/jtd.2019.01.64.
• Big data, big contributions: outcomes research in thoracic surgeryResio BJ, Dhanasopon AP, Blasberg JD. Big data, big contributions: outcomes research in thoracic surgery Journal Of Thoracic Disease 2019, 11: s566-s573. PMID: 31032075, PMCID: PMC6465425, DOI: 10.21037/jtd.2019.01.04.
• 03:00 PM Abstract No. 278 Thermal ablation versus stereotactic radiation therapy for stage 4 lung cancer: contemporary trends and outcomes from the National Cancer DatabaseUhlig J, Uhlig J, Dendy M, Goldberg S, Chiang A, Blasberg J, Kim H, Kim H. 03:00 PM Abstract No. 278 Thermal ablation versus stereotactic radiation therapy for stage 4 lung cancer: contemporary trends and outcomes from the National Cancer Database Journal Of Vascular And Interventional Radiology 2019, 30: s124-s125. DOI: 10.1016/j.jvir.2018.12.342.
• Short Tandem Repeats Define a Gestational Origin for Metastatic ChoriocarcinomaBrown K, Homer R, Baine M, Blasberg JD. Short Tandem Repeats Define a Gestational Origin for Metastatic Choriocarcinoma The Annals Of Thoracic Surgery 2019, 108: e115-e117. PMID: 30685255, DOI: 10.1016/j.athoracsur.2018.12.038.
• Corrigendum to ‘Delayed discharge does not decrease the cost of readmission after pulmonary lobectomy’ [Surgery 164/6 (2018) 1294–1299]Jean RA, Chiu AS, Boffa DJ, Detterbeck FC, Kim AW, Blasberg JD. Corrigendum to ‘Delayed discharge does not decrease the cost of readmission after pulmonary lobectomy’ [Surgery 164/6 (2018) 1294–1299] Surgery 2019, 165: 1058. PMID: 30678871, DOI: 10.1016/j.surg.2018.12.014.
• Variable impact of prior cancer history on the survival of lung cancer patientsMonsalve AF, Hoag JR, Resio BJ, Chiu AS, Brown LB, Detterbeck FC, Blasberg JD, Boffa DJ. Variable impact of prior cancer history on the survival of lung cancer patients Lung Cancer 2018, 127: 130-137. PMID: 30642541, DOI: 10.1016/j.lungcan.2018.11.040.
• Motivators, Barriers, and Facilitators to Traveling to the Safest Hospitals in the United States for Complex Cancer SurgeryResio BJ, Chiu AS, Hoag JR, Brown LB, White M, Omar A, Monsalve A, Dhanasopon AP, Blasberg JD, Boffa DJ. Motivators, Barriers, and Facilitators to Traveling to the Safest Hospitals in the United States for Complex Cancer Surgery JAMA Network Open 2018, 1: e184595. PMID: 30646367, PMCID: PMC6324377, DOI: 10.1001/jamanetworkopen.2018.4595.
• Identifying Drivers of Multiple Readmissions After Pulmonary LobectomyJean RA, Chiu AS, Hoag JR, Blasberg JD, Boffa DJ, Detterbeck FC, Kim AW. Identifying Drivers of Multiple Readmissions After Pulmonary Lobectomy The Annals Of Thoracic Surgery 2018, 107: 947-953. PMID: 30336117, DOI: 10.1016/j.athoracsur.2018.08.070.
• Why Travel for Complex Cancer Surgery? Americans React to ‘Brand-Sharing’ Between Specialty Cancer Hospitals and Their AffiliatesChiu AS, Resio B, Hoag JR, Monsalve AF, Blasberg JD, Brown L, Omar A, White MA, Boffa DJ. Why Travel for Complex Cancer Surgery? Americans React to ‘Brand-Sharing’ Between Specialty Cancer Hospitals and Their Affiliates Annals Of Surgical Oncology 2018, 26: 732-738. PMID: 30311158, DOI: 10.1245/s10434-018-6868-9.
• MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3)Rusch V, Chaft J, Johnson B, Wistuba I, Kris M, Lee J, Bunn P, Kwiatkowski D, Reckamp K, Finley D, Haura E, Waqar S, Doebele R, Garon E, Blasberg J, Nicholas A, Schulze K, Phan S, Gandhi M, Carbone D. MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3) Journal Of Thoracic Oncology 2018, 13: s369. DOI: 10.1016/j.jtho.2018.08.346.
• Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database Study.Uhlig J, Ludwig JM, Goldberg SB, Chiang A, Blasberg JD, Kim HS. Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database Study. Radiology 2018, 289: 862-870. PMID: 30226453, DOI: 10.1148/radiol.2018180979.
• Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected doseYe Q, Wu J, Lu Y, Naganawa M, Gallezot JD, Ma T, Liu Y, Tanoue L, Detterbeck F, Blasberg J, Chen MK, Casey M, Carson RE, Liu C. Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose Physics In Medicine And Biology 2018, 63: 175015. PMID: 30095083, PMCID: PMC6158045, DOI: 10.1088/1361-6560/aad97f.
• Beyond TNM: Searching for New Patient-Centric Prognostic Indicators in NSCLCSaffarzadeh AG, Blasberg JD. Beyond TNM: Searching for New Patient-Centric Prognostic Indicators in NSCLC Annals Of Surgical Oncology 2018, 25: 3425-3426. PMID: 30155757, DOI: 10.1245/s10434-018-6714-0.
• No sweat: Favorable outcomes of hyperhidrosis surgery with ageBlasberg JD, Resio BJ. No sweat: Favorable outcomes of hyperhidrosis surgery with age Journal Of Thoracic And Cardiovascular Surgery 2018, 156: 1759-1760. PMID: 30248806, DOI: 10.1016/j.jtcvs.2018.07.055.
• Delayed discharge does not decrease the cost of readmission after pulmonary lobectomyJean RA, Chiu AS, Boffa DJ, Detterbeck FC, Kim AW, Blasberg JD. Delayed discharge does not decrease the cost of readmission after pulmonary lobectomy Surgery 2018, 164: 1294-1299. PMID: 30064733, DOI: 10.1016/j.surg.2018.05.049.
• Defining the learning curve in robot-assisted thoracoscopic lobectomyArnold BN, Thomas DC, Bhatnagar V, Blasberg JD, Wang Z, Boffa DJ, Detterbeck FC, Kim AW. Defining the learning curve in robot-assisted thoracoscopic lobectomy Surgery 2018, 165: 450-454. PMID: 30061043, DOI: 10.1016/j.surg.2018.06.011.
• Seeing Through The Ground-Glass: Do Imaging Characteristics Really Matter?Blasberg JD, Resio B. Seeing Through The Ground-Glass: Do Imaging Characteristics Really Matter? Journal Of Thoracic And Cardiovascular Surgery 2018, 156: 1677-1678. PMID: 30098805, DOI: 10.1016/j.jtcvs.2018.06.055.
• Evaluation of ground glass nodulesMironova V, Blasberg JD. Evaluation of ground glass nodules Current Opinion In Pulmonary Medicine 2018, 24: 350-354. PMID: 29634577, DOI: 10.1097/mcp.0000000000000492.
• US Public Perceptions About Cancer Care Provided by Smaller Hospitals Associated With Large Hospitals Recognized for Specializing in Cancer CareChiu AS, Resio B, Hoag JR, Monsalve AF, Blasberg JD, White MA, Boffa DJ. US Public Perceptions About Cancer Care Provided by Smaller Hospitals Associated With Large Hospitals Recognized for Specializing in Cancer Care JAMA Oncology 2018, 4: 1008-1009. PMID: 29852033, PMCID: PMC6145726, DOI: 10.1001/jamaoncol.2018.1400.
• When good operations go bad: The additive effect of comorbidity and postoperative complications on readmission after pulmonary lobectomyJean RA, Chiu AS, Boffa DJ, Detterbeck FC, Blasberg JD, Kim AW. When good operations go bad: The additive effect of comorbidity and postoperative complications on readmission after pulmonary lobectomy Surgery 2018, 164: 294-299. PMID: 29801731, DOI: 10.1016/j.surg.2018.03.019.
• Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3).Rusch V, Chaft J, Johnson B, Wistuba I, Kris M, Lee J, Bunn P, Kwiatkowski D, Reckamp K, Finley D, Haura E, Waqar S, Doebele R, Garon E, Blasberg J, Nicholas A, Schulze K, Phan S, Gandhi M, Carbone D. Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3). Journal Of Clinical Oncology 2018, 36: 8541-8541. DOI: 10.1200/jco.2018.36.15_suppl.8541.
• Progress in the Management of Early-Stage Non–Small Cell Lung Cancer in 2017Donington JS, Kim YT, Tong B, Moreira AL, Bessich J, Weiss KD, Colson YL, Wigle D, Osarogiagbon RU, Zweig J, Wakelee H, Blasberg J, Daly M, Backhus L, Van Schil P. Progress in the Management of Early-Stage Non–Small Cell Lung Cancer in 2017 Journal Of Thoracic Oncology 2018, 13: 767-778. PMID: 29654928, DOI: 10.1016/j.jtho.2018.04.002.
• Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal AdenocarcinomaSEDER CW, MAHON B, HENNON M, THOMAS M, LEVEA CM, MATKOWSKYJ KA, KRISHNA M, MEDAIROS R, MACKE RA, BASU S, BLASBERG JD. Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma Anticancer Research 2018, 38: 2195-2200. PMID: 29599339, DOI: 10.21873/anticanres.12461.
• Robotic-Assisted Lobectomies in the National Cancer DatabaseArnold BN, Thomas DC, Narayan R, Blasberg JD, Detterbeck FC, Boffa DJ, Kim AW. Robotic-Assisted Lobectomies in the National Cancer Database Journal Of The American College Of Surgeons 2018, 226: 1052-1062.e15. PMID: 29574177, DOI: 10.1016/j.jamcollsurg.2018.03.023.
• Timing and Risk Factors Associated With Venous Thromboembolism After Lung Cancer ResectionThomas DC, Arnold BN, Hoag JR, Salazar MC, Detterbeck FC, Boffa DJ, Kim AW, Blasberg JD. Timing and Risk Factors Associated With Venous Thromboembolism After Lung Cancer Resection The Annals Of Thoracic Surgery 2018, 105: 1469-1475. PMID: 29501644, DOI: 10.1016/j.athoracsur.2018.01.072.
• Spontaneous regionalization of esophageal cancer surgery: an analysis of the National Cancer DatabaseArnold BN, Chiu AS, Hoag JR, Kim CH, Salazar MC, Blasberg JD, Boffa DJ. Spontaneous regionalization of esophageal cancer surgery: an analysis of the National Cancer Database Journal Of Thoracic Disease 2018, 10: 1721-1731. PMID: 29707326, PMCID: PMC5906219, DOI: 10.21037/jtd.2018.02.12.
• Primary Salivary Type Lung Cancers in the National Cancer DatabaseResio BJ, Chiu AS, Hoag J, Dhanasopon AP, Blasberg JD, Boffa DJ. Primary Salivary Type Lung Cancers in the National Cancer Database The Annals Of Thoracic Surgery 2018, 105: 1633-1639. PMID: 29486180, DOI: 10.1016/j.athoracsur.2018.01.055.
• Robotic Transthoracic Primary Repair of a Diaphragmatic Hernia and Reduction of an Intrathoracic LiverCounts SJ, Saffarzadeh AG, Blasberg JD, Kim AW. Robotic Transthoracic Primary Repair of a Diaphragmatic Hernia and Reduction of an Intrathoracic Liver Innovations Technology And Techniques In Cardiothoracic And Vascular Surgery 2018, 13: 54-55. PMID: 29443817, DOI: 10.1097/imi.0000000000000455.
• Chapter 8 Special Types of Lung CancerBlasberg J, Kim C, Chilakamarry S. Chapter 8 Special Types of Lung Cancer 2018, 131-146. DOI: 10.1016/b978-0-323-48565-4.00008-4.
• Robotic Transthoracic Primary Repair of a Diaphragmatic Hernia and Reduction of an Intrathoracic LiverCounts S, Saffarzadeh A, Blasberg J, Kim A. Robotic Transthoracic Primary Repair of a Diaphragmatic Hernia and Reduction of an Intrathoracic Liver Innovations Technology And Techniques In Cardiothoracic And Vascular Surgery 2018, 13: 54-55. DOI: 10.1177/155698451801300110.
• Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging SystemDhanasopon AP, Salazar MC, Hoag JR, Rosen JE, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System The Annals Of Thoracic Surgery 2017, 104: 1829-1836. PMID: 29074151, DOI: 10.1016/j.athoracsur.2017.06.073.
• Not Just Done in VeinBlasberg JD, Kim AW. Not Just Done in Vein Seminars In Thoracic And Cardiovascular Surgery 2017, 29: 431-432. PMID: 28967538, DOI: 10.1053/j.semtcvs.2017.08.011.
• The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung CancerThomas DC, Arnold BN, Rosen JE, Salazar MC, Detterbeck FC, Blasberg JD, Boffa DJ, Kim AW. The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer World Journal Of Surgery 2017, 42: 161-171. PMID: 28799084, DOI: 10.1007/s00268-017-4165-6.
• Effectiveness of local therapy for stage I non–small-cell lung cancer in nonagenariansArnold BN, Thomas DC, Rosen JE, Salazar MC, Detterbeck FC, Blasberg JD, Boffa DJ, Kim AW. Effectiveness of local therapy for stage I non–small-cell lung cancer in nonagenarians Surgery 2017, 162: 640-651. PMID: 28697883, DOI: 10.1016/j.surg.2017.04.025.
• The impact of tumor size on survival in T3 non-small cell lung-cancer with direct extension.Kim C, Salazar M, Hoag J, Rosen J, Arnold B, Boffa D, Blasberg J. The impact of tumor size on survival in T3 non-small cell lung-cancer with direct extension. Journal Of Clinical Oncology 2017, 35: e20033-e20033. DOI: 10.1200/jco.2017.35.15_suppl.e20033.
• Validating the Thoracic Revised Cardiac Risk Index Following Lung ResectionThomas DC, Blasberg JD, Arnold BN, Rosen JE, Salazar MC, Detterbeck FC, Boffa DJ, Kim AW. Validating the Thoracic Revised Cardiac Risk Index Following Lung Resection The Annals Of Thoracic Surgery 2017, 104: 389-394. PMID: 28499655, DOI: 10.1016/j.athoracsur.2017.02.006.
• Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer SurgerySalazar MC, Rosen JE, Wang Z, Arnold BN, Thomas DC, Herbst RS, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery JAMA Oncology 2017, 3: 610-619. PMID: 28056112, PMCID: PMC5824207, DOI: 10.1001/jamaoncol.2016.5829.
• The Society of Thoracic Surgeons Composite Score for Evaluating Esophagectomy for Esophageal CancerForce T, Chang A, Kosinski A, Raymond D, Magee M, DeCamp M, Farjah F, Grogan E, Seder C, Allen M, Blasberg J, Blackmon S, Burfeind W, Cassivi S, Park B, Shahian D, Wormuth D, Han J, Wright C, Fernandez F, Kozower B. The Society of Thoracic Surgeons Composite Score for Evaluating Esophagectomy for Esophageal Cancer The Annals Of Thoracic Surgery 2017, 103: 1661-1667. PMID: 28385375, DOI: 10.1016/j.athoracsur.2016.10.027.
• ResponseTchouta LN, Park HS, Boffa DJ, Blasberg JD, Detterbeck FC, Kim AW. Response CHEST Journal 2017, 151: 942-943. PMID: 28390633, DOI: 10.1016/j.chest.2017.01.017.
• Black Esophagus, White Esophagus, or Shades of Gray?Blasberg JD. Black Esophagus, White Esophagus, or Shades of Gray? Seminars In Thoracic And Cardiovascular Surgery 2017, 29: 260-261. PMID: 28823341, DOI: 10.1053/j.semtcvs.2017.03.003.
• What and how to read: Staying current as a young cardiothoracic surgeonBlasberg JD, Krantz SB. What and how to read: Staying current as a young cardiothoracic surgeon Journal Of Thoracic And Cardiovascular Surgery 2017, 154: 558-562. PMID: 28433361, DOI: 10.1016/j.jtcvs.2017.03.052.
• Anesthesia for nonintubated video-assisted thoracic surgerySunaga H, Blasberg JD, Heerdt PM. Anesthesia for nonintubated video-assisted thoracic surgery Current Opinion In Anaesthesiology 2017, 30: 1-6. PMID: 27906718, DOI: 10.1097/aco.0000000000000413.
• Organization, Teamwork and Quality of Care in Thoracic Surgery A Model for High Reliability Care Delivery.Detterbeck FC, Zurich HB, Agarwal R, Blasberg JD, Boffa DJ, Delrossi EP, Finan ME, Hindinger KK, Kim AW, Pierson M. Organization, Teamwork and Quality of Care in Thoracic Surgery A Model for High Reliability Care Delivery. Connecticut Medicine 2017, 81: 5-12. PMID: 29782759.
• Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgeryThomas DC, Arnold BN, Rosen JE, Salazar MC, Blasberg JD, Detterbeck FC, Boffa DJ, Kim AW. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery Lung Cancer 2016, 103: 75-81. PMID: 28024700, DOI: 10.1016/j.lungcan.2016.11.016.
• Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest WallGao SJ, Corso CD, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall Clinical Lung Cancer 2016, 18: 169-177.e4. PMID: 27890561, DOI: 10.1016/j.cllc.2016.08.005.
• Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non–Small Cell Lung CancerGao SJ, Corso CD, Wang EH, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non–Small Cell Lung Cancer Journal Of Thoracic Oncology 2016, 12: 314-322. PMID: 27720827, DOI: 10.1016/j.jtho.2016.09.122.
• Chest Discomfort and Longstanding Dyspnea on ExertionMacke RA, Templin TP, Blasberg JD. Chest Discomfort and Longstanding Dyspnea on Exertion JAMA Surgery 2016, 151: 979-980. PMID: 27533325, DOI: 10.1001/jamasurg.2016.2043.
• Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal InvolvementGao S, Corso C, Wang E, Blasberg J, Boffa D, Detterbeck F, Kim A. Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal Involvement International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e470. DOI: 10.1016/j.ijrobp.2016.06.1811.
• Hospital Volume and Outcomes of Robot-Assisted LobectomiesTchouta LN, Park HS, Boffa DJ, Blasberg JD, Detterbeck FC, Kim AW. Hospital Volume and Outcomes of Robot-Assisted Lobectomies CHEST Journal 2016, 151: 329-339. PMID: 27687847, DOI: 10.1016/j.chest.2016.09.008.
• Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of AdoptionBlasberg JD, Seder CW, Leverson G, Shan Y, Maloney JD, Macke RA. Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption The Annals Of Thoracic Surgery 2016, 102: 1854-1862. PMID: 27592603, DOI: 10.1016/j.athoracsur.2016.06.030.
• The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomiesJawitz OK, Wang Z, Boffa DJ, Detterbeck FC, Blasberg JD, Kim AW. The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies European Journal Of Cardio-Thoracic Surgery 2016, 51: 169-174. PMID: 27458143, DOI: 10.1093/ejcts/ezw239.
• Correlation of FDG PET/CT heterogeneity with disease recurrence in early-stage, non-small cell lung cancer.Blasberg J, Harmon S, Seder C, Traynor A, Jeraj R. Correlation of FDG PET/CT heterogeneity with disease recurrence in early-stage, non-small cell lung cancer. Journal Of Clinical Oncology 2016, 34: e20049-e20049. DOI: 10.1200/jco.2016.34.15_suppl.e20049.
• Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data BaseArnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ, Detterbeck FC, Kim AW. Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base Journal Of Thoracic Oncology 2016, 11: 1121-1131. PMID: 27103511, DOI: 10.1016/j.jtho.2016.03.023.
• Outpatient air leak management after lobectomy: a CMS cost analysisSchmocker RK, Vanness DJ, Macke RA, Akhter SA, Maloney JD, Blasberg JD. Outpatient air leak management after lobectomy: a CMS cost analysis Journal Of Surgical Research 2016, 203: 390-397. PMID: 27363648, PMCID: PMC4926869, DOI: 10.1016/j.jss.2016.03.043.
• Adjuvant Chemotherapy for T3 Non–Small Cell Lung Cancer with Additional Tumor Nodules in the Same LobeSalazar MC, Rosen JE, Arnold BN, Thomas DC, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Adjuvant Chemotherapy for T3 Non–Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe Journal Of Thoracic Oncology 2016, 11: 1090-1100. PMID: 27013407, DOI: 10.1016/j.jtho.2016.03.009.
• Resection is safe for patients with stage IIIA NSCLC undergoing multimodality therapyLushaj E, Julliard W, Bretl T, Badami A, Macke R, Blasberg J, Maloney J. Resection is safe for patients with stage IIIA NSCLC undergoing multimodality therapy Cancer Treatment And Research Communications 2016, 5: 22-25. DOI: 10.1016/j.ctrc.2015.12.002.
• The Surgical Apgar Score in esophagectomyJanowak CF, Blasberg JD, Taylor L, Maloney JD, Macke RA. The Surgical Apgar Score in esophagectomy Journal Of Thoracic And Cardiovascular Surgery 2015, 150: 806-812. PMID: 26234458, DOI: 10.1016/j.jtcvs.2015.07.017.
• Tracheal ResectionBlasberg J, Mathisen D. Tracheal Resection 2014, 173-191. DOI: 10.1007/978-3-642-54565-8_18.
• Surgical Considerations in Tracheal and Carinal ResectionBlasberg JD, Wright CD. Surgical Considerations in Tracheal and Carinal Resection Seminars In Cardiothoracic And Vascular Anesthesia 2012, 16: 190-195. PMID: 22743220, DOI: 10.1177/1089253212450342.
• Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening populationJoseph S, Harrington R, Walter D, Goldberg JD, Li X, Beck A, Litton T, Hirsch N, Blasberg J, Slomiany M, Rom W, Pass H, Donington J. Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population Cancer Biomarkers 2012, 12: 177-184. PMID: 23568008, PMCID: PMC3746829, DOI: 10.3233/cbm-130306.
• Management of Early Stage Non–Small Cell Lung Cancer in High-Risk PatientsDonington JS, Blasberg JD. Management of Early Stage Non–Small Cell Lung Cancer in High-Risk Patients Thoracic Surgery Clinics 2011, 22: 55-65. PMID: 22108689, DOI: 10.1016/j.thorsurg.2011.08.018.
• The role of gender in coronary surgeryBlasberg JD, Schwartz GS, Balaram SK. The role of gender in coronary surgery European Journal Of Cardio-Thoracic Surgery 2011, 40: 715-721. PMID: 21349733, DOI: 10.1016/j.ejcts.2011.01.003.
• Onconase mediated NFKβ downregulation in malignant pleural mesotheliomaGoparaju CM, Blasberg JD, Volinia S, Palatini J, Ivanov S, Donington JS, Croce C, Carbone M, Yang H, Pass HI. Onconase mediated NFKβ downregulation in malignant pleural mesothelioma Oncogene 2011, 30: 2767-2777. PMID: 21317924, PMCID: PMC3118086, DOI: 10.1038/onc.2010.643.
• Infections and Radiation Injuries Involving the Chest WallBlasberg JD, Donington JS. Infections and Radiation Injuries Involving the Chest Wall Thoracic Surgery Clinics 2010, 20: 487-494. PMID: 20974432, DOI: 10.1016/j.thorsurg.2010.06.003.
• Sublobar Resection: A Movement from the Lung Cancer Study GroupBlasberg JD, Pass HI, Donington JS. Sublobar Resection: A Movement from the Lung Cancer Study Group Journal Of Thoracic Oncology 2010, 5: 1583-1593. PMID: 20879185, DOI: 10.1097/jto.0b013e3181e77604.
• Functional Heterogeneity of Osteopontin Isoforms in Non-small Cell Lung CancerGoparaju CM, Pass HI, Blasberg JD, Hirsch N, Donington JS. Functional Heterogeneity of Osteopontin Isoforms in Non-small Cell Lung Cancer Journal Of Thoracic Oncology 2010, 5: 1516-1523. PMID: 20689445, PMCID: PMC3122268, DOI: 10.1097/jto.0b013e3181eba6bd.
• Robotic Brachytherapy and Sublobar Resection for T1 Non-Small Cell Lung Cancer in High-Risk PatientsBlasberg JD, Belsley SJ, Schwartz GS, Evans A, Wernick I, Ashton RC, Bhora FY, Connery CP. Robotic Brachytherapy and Sublobar Resection for T1 Non-Small Cell Lung Cancer in High-Risk Patients The Annals Of Thoracic Surgery 2010, 89: 360-367. PMID: 20103299, DOI: 10.1016/j.athoracsur.2009.09.052.
• Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung CancerBlasberg JD, Pass HI, Goparaju CM, Flores RM, Lee S, Donington JS. Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung Cancer Journal Of Clinical Oncology 2010, 28: 936-941. PMID: 20085934, PMCID: PMC2834433, DOI: 10.1200/jco.2009.25.5711.
• Chapter 18 The Role of Sex and Gender in Cardiothoracic SurgeryBalaram S, Blasberg J. Chapter 18 The Role of Sex and Gender in Cardiothoracic Surgery 2010, 200-212. DOI: 10.1016/b978-0-12-374271-1.00018-6.
• Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneityBlasberg JD, Goparaju CM, Pass HI, Donington JS. Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity Journal Of Thoracic And Cardiovascular Surgery 2009, 139: 1587-1593. PMID: 19818970, PMCID: PMC2875279, DOI: 10.1016/j.jtcvs.2009.08.016.
• Isolated bladder metastasis causing large bowel obstruction: a case report of an atypical presentation of intussusceptionBlasberg JD, Schwartz G, Mull JA, Moore E. Isolated bladder metastasis causing large bowel obstruction: a case report of an atypical presentation of intussusception Cases Journal 2009, 2: 7124. PMID: 19829915, PMCID: PMC2740015, DOI: 10.4076/1757-1626-2-7124.
• Reduction of elevated plasma osteopontin levels with resection of non-small cell lung cancer (NSCLC)Blasberg J, Pass H, Flores R, Donington J. Reduction of elevated plasma osteopontin levels with resection of non-small cell lung cancer (NSCLC) Journal Of Clinical Oncology 2009, 27: 11019-11019. DOI: 10.1200/jco.2009.27.15_suppl.11019.